Coffin, L. S., Newberry, A., Hagan, H., Cleland, C. M., Des Jarlais, D. C., & Perlman, D. C. (2010). Syphilis in drug users in low and middle income countries. International Journal of Drug Policy, 21 (1), 20-27.

Des Jarlais, D. C., Arasteh, K., Hagan, H., McKnight, C., Perlman, D. C., & Friedman, S. R. (2009). Persistence and change in disparities in HIV infection among injection drug users in New York City after large-scale syringe exchange programs. American Journal of Public Health, 99 (Suppl 2), S445-S451.

Friedman, S. R., Cooper, H. L., & Osborne, A. H. (2009). Structural and social contexts of HIV risk among African Americans. American Journal of Public Health, 99 (6), 1002-1008.

Semaan, S., Santibanez, S., Garfein, R. S., Heckathorn, D. D., & Des Jarlais, D. C. (2009). Ethical and regulatory considerations in HIV prevention studies employing respondent-driven sampling. International Journal of Drug Policy, 20 (1), 14-27.

Friedman, S. R., Rossi, D., & Phaswana-Mafuya, N. (2009). Globalization and interacting large-scale processes and how they may affect the HIV/AIDS epidemic. In C. Pope, R. T. White, & R. Malow (Eds.), HIV/AIDS: Global frontiers in prevention/intervention (491-499). New York: Routledge.

Friedman, S. R., Rossi, D., & Braine, N. (2009). Theorizing "Big Events" as a potential risk environment for drug use, drug-related harm and HIV epidemic outbreaks. International Journal of Drug Policy, 20 (3), 283-291.

Braine, N., Acker, C., Goldblatt, C., Yi, H., Friedman, S., & Des Jarlais, D. C. (2008). Neighborhood history as a factor shaping syringe distribution networks among drug users at a U.S. syringe exchange. Social Networks, 30 (3), 235-246.

Shedlin, M. G., Arauz, R., Ortells, P., Aburto, M., & Norori, D. (2008). Factors influencing drug use and HIV risk in two Nicaraguan cities. In Y. F. Thomas, D. Richardson, & I. Cheung (Eds.), Geography and drug addiction (267-285). New York: Springer.

Des Jarlais, D. C., & Semaan, S. (2008). HIV and other sexually transmitted infections in injection drug users and crack cocaine smokers. In K. K. Holmes, P. F. Sparling, W. E. Stamm, P. Piot, J. N. Wasserheit, L. Corey, L. Cohen &. D. H. Watts (Eds.), Sexually transmitted diseases (4th ed., 237-255). New York: Mc-Graw-Hill.

Des Jarlais, D. C., Kling, R., Hammett, T. M., Ngu, D., Liu, W., Chen, Y., Binh, K. T., & Friedmann, P. (2007). Reducing HIV infection among new injecting drug users in the China-Vietnam Cross Border Project. AIDS, 21 (Supplement 8), S109-S114.

Gwadz, M. V., Nish, D., Leonard, N. R., & Strauss, S. M. (2007). Gender differences in traumatic events and rates of post-traumatic stress disorder among homeless youth. Journal of Adolescence, 30 (1), 117-129.

Cleland, C. M., Deren, S., Fuller, C. M., Blaney, S., McMahon, J. M., Tortu, S., Des Jarlais, D. C., & Vlahov, D. (2007). Syringe disposal among injection drug users in Harlem and the Bronx during the New York State Expanded Syringe Access Demonstration Program. Health Education and Behavior, 34 (2), 390-403.

Friedman, S. R., de Jong, W., Rossi, D., Touze, G., Rockwell, R., Des Jarlais, D. C., & Elovich, R. (2007). Harm reduction theory: Users’ culture, micro-social indigenous harm reduction, and the self-organization and outside-organizing of users’ groups. International Journal of Drug Policy, 18 (2), 107-117.

Scheinmann, R., Hagan, H., Lelutiu-Weinberger, C., Stern, R., Des Jarlais, D. C., Flom, P. L., & Strauss, S. (2007). Non-injection drug use and hepatitis C virus: A systematic review. Drug and Alcohol Dependence, 89 (1), 1-12.

Friedman, S. R., Bolyard, M., Mateu-Gelabert, P., Goltzman, P., Pawlowicz, M. P., Singh, D. Z., Touze, G., Rossi, D., Maslow, C., Sandoval, M., & Flom, P. L. (2007). Some data-driven reflections on priorities in AIDS network research. AIDS and Behavior, 11 (5), 641-651.

Hagan, H., Des Jarlais, D. C., Stern, R., Lelutiu-Weinberger, C., Scheinmann, R., Strauss, S., & Flom, P. L. (2007). HCV Synthesis Project: Preliminary analyses of HCV prevalence in relation to age and duration of injection. International Journal of Drug Policy, 18 (5), 341-351.

Friedman, S. R., Cavalieri, W., Crofts, N., Walsh, N., Madden, A., & Taylor, A. (2007). Hepatitis C prevention and care for injecting drug users. International Journal of Drug Policy, 18 (5), 333-334.

Des Jarlais, D. C., Hagan, H., Arasteh, K., McKnight, C., Perlman, D., & Friedman, S. R. (2007). Herpes simplex virus-2 and HIV among noninjecting drug users in New York City. Sexually Transmitted Diseases, 34 (11), 923-927.

Friedman, S. R., Bolyard, M., Maslow, C., Mateu-Gelabert, P., Sandoval, M., Ritvo, P., & Zenilman, J. (2007). Dificultades potenciales en la implementacion a nivel comunitario de la vacunacion contra el HIV: Lecciones de la vacunacion contra la hepatitis B. Actualizaciones En SIDA, 15 (58), 139-147.

Cleland, C. M., Des Jarlais, D. C., Perlis, T. E., Stimson, G., & Poznyak, V. (2007). HIV risk behaviors among female IDUs in developing and transitional countries. BMC Public Health, 7, 271.

Stimson, G. V., Fitch, C., Des Jarlais, D., Poznyak, V., Perlis, T., Oppenheimer, E., & Rhodes, T. (2006). Rapid assessment and response studies of injection drug use: Knowledge gain, capacity building, and intervention development in a multisite study. American Journal of Public Health, 96 (2), 288-295.

Friedman, S. R., & Touze, G. (2006). Policy bereft of research or theory: A failure of harm reduction science. International Journal of Drug Policy, 17 (2), 133-135.

Friedman, S. R., Kippax, S. C., Phaswana-Mafuya, N., Rossi, D., & Newman, C. E. (2006). Emerging future issues in HIV/AIDS social research. AIDS, 20 (7), 959-965.

Friedman, S., Rossi, D., & Flom, P. L. (2006). "Big events" and networks. Connections, 27 (1), 9-14.

Blankenship, K. M., Friedman, S. R., Dworkin, S., & Mantell, J. E. (2006). Structural interventions: Concepts, challenges and opportunities for research. Journal of Urban Health, 83 (1), 59-72.

Strauss, S. M., Rindskopf, D. M., Astone-Twerell, J. M., Des Jarlais, D. C., & Hagan, H. (2006). Using latent class analysis to identify patterns of hepatitis C service provision in drug-free treatment programs in the US. Drug and Alcohol Dependence, 83 (1), 15-24.

Des Jarlais, D. C., Perlis, T. E., Stimson, G. V., Poznyak, V., & WHO Phase II Drug Injection Collaborative Study Group (2006). Using standardized methods for research on HIV and injecting drug use in developing/transitional countries: Case study from the WHO Drug Injection Study Phase II. BMC Public Health, 6:54.

Johnson, B. D., Golub, A., Deren, S., Des Jarlais, D. C., Fuller, C., & Vlahov, D. (2006). The nonimpact of the Expanded Syringe Access Program upon heroin use, injection behaviours, and crime indicators in New York City and State. Justice Research and Policy, 8 (1), 27-49.

Flom, P. L., Zenilman, J. M., Sandoval, M., Kottiri, B. J., & Friedman, S.R. (2005). Seroprevalence and correlates of Herpes Simplex Virus Type 2 infection among young adults in a low-income minority neighborhood. Journal of Infectious Diseases, 191 (5), 818-820.

Rhodes, T., Singer, M., Bourgois, P., Friedman, S. R., & Strathdee, S. A. (2005). The social structural production of HIV risk among injecting drug users. Social Science and Medicine, 61 (5), 1026-1044.

Krahn, M. D., John-Baptiste, A., Yi, Q., Doria, A., Remis, R. S., Ritvo, P., & Friedman, S. (2005). Potential cost-effectiveness of a preventive hepatitis C vaccine in high risk and average risk populations in Canada. Vaccine, 23 (13), 1549-1558.

Flom, P. L. (2005). A LATEX fledgling struggles to take flight. PracTEX Journal, 2.

Pouget, E. R., Deren, S., Fuller, C. M., Blaney, S., McMahon, J. M., Kang, S. Y., Tortu, S., Andia, J. F., Des Jarlais, D. C., & Vlahov, D. (2005). Receptive syringe sharing among injection drug users in Harlem and the Bronx during the New York State Expanded Syringe Access Demonstration Program. Journal of Acquired Immune Deficiency Syndromes, 39 (4), 471-477.

Des Jarlais, D. C., & Semaan, S. (2005). Interventions to reduce the sexual risk behaviour of injecting drug users. International Journal of Drug Policy, 16 (Supplement 1), S58-S66.

Vassilev, Z. P., & Hagan, H. (2004). Highly active antiretroviral therapy for injection drug users: Physician-recommended strategies for enhanced adherence. Antiviral Therapy, 9 (3), 461.

Flom, P. L., Friedman, S. R., Strauss, S. M., & Neaigus, A. (2004). A new measure of linkage between two sub-networks. Connections, 26 (1), 62-70.

Flom, P. L., & Strauss, S. M. (2003). Some graphical methods for interpreting interactions in logistic and OLS regression. Multiple Linear Regression Viewpoints, 29 (1), 1-7.

Deren, S., Fuller, C., Pouget, E. R., Blaney, S., Tortu, S., Kang, S. Y., McMahon, J. M., Andia, J. F., Des Jarlais, D. C., Johnson, B., Rosenblum, A., & Vlahov, D. (2003). Impact of expanding syringe access in New York on sources of syringes for injection drug users in Harlem and the Bronx, NYC, USA. International Journal of Drug Policy, 14 (5), 373-379.

Friedman, S. R. (2003). Thoughts on a theory of drug-use trends. Addiction Research and Theory, 11 (1), 43-45.

Friedman, S. R., & Knight, K. (2003). What is the role of structural interventions in HIV prevention?. University of California, San Francisco, Center for AIDS Prevention Studies Fact Sheet.

Hagan, H. (2003). The relevance of attributable risk measures to HIV prevention planning. AIDS, 17 (6), 911-913.

Rindskopf, D. M., Strauss, S. M., Falkin, G. P., & Deren, S. (2003). Assessing the consequences of using self-report data to determine the correlates of HIV status: Conditional and marginal approaches. Multivariate Behavioral Research, 38 (3), 325-352.

Rosenblum, A., Joseph, H., Fong, C., Kipnis, S., Cleland, C., & Portenoy, R. K. (2003). Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities. Journal of the American Medical Association, 289 (18), 2370-2378.

Rockwell, R., Deren, S., Goldstein, M. F., Friedman, S. R., & Des Jarlais, D. C. (2002). Trends in the AIDS epidemic among New York City's injection drug users: Localized or citywide?. Journal of Urban Health, 79 (1), 136-146.

Friedman, S. R. (2002). Sociopharmacology of drug use: Initial thoughts. International Journal of Drug Policy, 13 (5), 341-347.

Friedman, S. R., & Reid, G. (2002). The need for dialectical models as shown in the response to the HIV/AIDS epidemic. International Journal of Sociology and Social Policy, 22, 177-200.

Friedman, S. R., Neaigus, A., Sandoval, M., Mateu-Gelabert, P., Flom, P. L., Kottiri, B. J., Fuld, J., Krauss, B., & Des Jarlais, D. C. (2002). What risk networks and social networks can contribute to understanding and preventing the spread of HIV. In 2001 Global Research Network meeting on HIV prevention in drug-using populations: Fourth Annual Meeting Report (19-25). Rockville, MD: National Institute on Drug Abuse.

Choopanya, K., Des Jarlais, D. C., Vanichseni, S., Kitayaporn, D., Mock, P. A., Raktham, S., Hireanras, K., Heyward, W. L., Sujarita, S., & Mastro, T. D. (2002). Incarceration and risk for HIV infection among injection drug users in Bangkok. Journal of Acquired Immune Deficiency Syndromes, 29 (1), 86-94.

Deren, S., Shedlin, M., Hamilton, T., & Hagan, H. (2002). Impact of the September 11th attacks in New York City on drug users: A preliminary assessment. Journal of Urban Health, 79 (3), 409-412.

Des Jarlais, D. C., Friedmann, P., Grund, J-P., Milliken, J., Titus, S., Zadoretsky, C., Perlis, T., Bodrova, V., & Zemlianova, E. (2002). HIV risk behaviour among participants of syringe exchange programmes in central/eastern Europe and Russia. International Journal of Drug Policy, 13 (3), 165-170.

Deren, S., Robles, R., Andia, J., Colon, H. M., Kang, S. Y., & Perlis, T. (2001). Trends in HIV seroprevalence and needle sharing among Puerto Rican drug injectors in Puerto Rico and New York: 1992-1999. Journal of Acquired Immune Deficiency Syndromes, 26 (2), 164-169.

Friedman, S. R., Perlis, T., & Des Jarlais, D. C. (2001). Laws prohibiting over-the-counter syringe sales to injection drug users: Relations to population density, HIV prevalence, and HIV incidence. American Journal of Public Health, 91 (5), 791-793.

Friedman, S. R., Lynch, J., Perlis, T., & Des Jarlais, D. C. (2000). Economic inequality, poverty, and laws against syringe access as predictors of metropolitan area rates of drug injection and HIV infection. In 2000 Global Research Network meeting on HIV prevention in drug-using populations: Third Annual Meeting Report (147-149). Rockville, MD: National Institute on Drug Abuse.

Des Jarlais, D. C., Marmor, M., Friedmann, P., Titus, S., Aviles, E., Deren, S., Torian, L., Glebatis, D., Murrill, C., Monterroso, E., & Friedman, S. R. (2000). HIV incidence among injection drug users in New York City, 1992-1997: Evidence for a declining epidemic. American Journal of Public Health, 90 (3), 352-359.

Friedman, S. R. (2000). What hath RAR wrought?. International Journal of Drug Policy, 11 (1), 37-39.